The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Postoperative Nausea and Vomiting Management Market Research Report 2025
Synopsis
Postoperative nausea and vomiting (PONV) management refers to the various strategies and interventions used to prevent or treat nausea and vomiting in patients after surgery.
Global Postoperative Nausea and Vomiting Management market is projected to reach US$ 2346.5 million in 2029, increasing from US$ 1040 million in 2022, with the CAGR of 12.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Postoperative Nausea and Vomiting Management market research.
The postoperative nausea and vomiting (PONV) management market is driven by the increasing number of surgical procedures and the growing awareness about the adverse effects of PONV on patients' recovery and satisfaction. Anesthesia-induced nausea and vomiting are common complications after surgery, and effective PONV management is crucial to enhance patient outcomes and reduce healthcare costs associated with extended hospital stays and additional treatments. As a result, there is a rising demand for pharmacological and non-pharmacological interventions, such as antiemetic medications, acupressure, and enhanced recovery protocols, to prevent and alleviate PONV. However, the market also faces challenges, including the variability in individual patient responses to antiemetic treatments and the risk of adverse effects associated with certain medications. Additionally, the availability and affordability of effective PONV management options in different healthcare settings can vary, especially in resource-limited regions. Overcoming these challenges through ongoing research and innovation in PONV management approaches, personalized patient care, and education of healthcare professionals will be essential in driving the growth of the postoperative nausea and vomiting management market and improving the post-surgical experience for patients worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Postoperative Nausea and Vomiting Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Acacia Pharma
Roche
Novartis AG
Ani Pharmaceuticals, Inc
Camurus AB
Sanofi S.A.
Helsinn Holding S.A.
Eisai Corporation
Merck and Co.
GlaxoSmithKline
Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
Neurokinin NK-1 Receptor Antagonists
Non-pharmacological Treatment
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Postoperative Nausea and Vomiting Management report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Postoperative nausea and vomiting (PONV) management refers to the various strategies and interventions used to prevent or treat nausea and vomiting in patients after surgery.
Global Postoperative Nausea and Vomiting Management market is projected to reach US$ 2346.5 million in 2029, increasing from US$ 1040 million in 2022, with the CAGR of 12.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Postoperative Nausea and Vomiting Management market research.
The postoperative nausea and vomiting (PONV) management market is driven by the increasing number of surgical procedures and the growing awareness about the adverse effects of PONV on patients' recovery and satisfaction. Anesthesia-induced nausea and vomiting are common complications after surgery, and effective PONV management is crucial to enhance patient outcomes and reduce healthcare costs associated with extended hospital stays and additional treatments. As a result, there is a rising demand for pharmacological and non-pharmacological interventions, such as antiemetic medications, acupressure, and enhanced recovery protocols, to prevent and alleviate PONV. However, the market also faces challenges, including the variability in individual patient responses to antiemetic treatments and the risk of adverse effects associated with certain medications. Additionally, the availability and affordability of effective PONV management options in different healthcare settings can vary, especially in resource-limited regions. Overcoming these challenges through ongoing research and innovation in PONV management approaches, personalized patient care, and education of healthcare professionals will be essential in driving the growth of the postoperative nausea and vomiting management market and improving the post-surgical experience for patients worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Postoperative Nausea and Vomiting Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Acacia Pharma
Roche
Novartis AG
Ani Pharmaceuticals, Inc
Camurus AB
Sanofi S.A.
Helsinn Holding S.A.
Eisai Corporation
Merck and Co.
GlaxoSmithKline
Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
Neurokinin NK-1 Receptor Antagonists
Non-pharmacological Treatment
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Postoperative Nausea and Vomiting Management report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 Neurokinin NK-1 Receptor Antagonists
1.2.6 Non-pharmacological Treatment
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting Management Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting Management Market Perspective (2018-2029)
2.2 Postoperative Nausea and Vomiting Management Growth Trends by Region
2.2.1 Global Postoperative Nausea and Vomiting Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Postoperative Nausea and Vomiting Management Historic Market Size by Region (2018-2023)
2.2.3 Postoperative Nausea and Vomiting Management Forecasted Market Size by Region (2024-2029)
2.3 Postoperative Nausea and Vomiting Management Market Dynamics
2.3.1 Postoperative Nausea and Vomiting Management Industry Trends
2.3.2 Postoperative Nausea and Vomiting Management Market Drivers
2.3.3 Postoperative Nausea and Vomiting Management Market Challenges
2.3.4 Postoperative Nausea and Vomiting Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting Management Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting Management Players by Revenue (2018-2023)
3.1.2 Global Postoperative Nausea and Vomiting Management Revenue Market Share by Players (2018-2023)
3.2 Global Postoperative Nausea and Vomiting Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting Management Revenue
3.4 Global Postoperative Nausea and Vomiting Management Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting Management Revenue in 2022
3.5 Postoperative Nausea and Vomiting Management Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting Management Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting Management Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2024-2029)
5 Postoperative Nausea and Vomiting Management Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Postoperative Nausea and Vomiting Management Market Size (2018-2029)
6.2 North America Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
6.4 North America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting Management Market Size (2018-2029)
7.2 Europe Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
7.4 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size (2018-2029)
8.2 Asia-Pacific Postoperative Nausea and Vomiting Management Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting Management Market Size (2018-2029)
9.2 Latin America Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
9.4 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size (2018-2029)
10.2 Middle East & Africa Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Detail
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting Management Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.1.5 Acacia Pharma Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Postoperative Nausea and Vomiting Management Introduction
11.2.4 Roche Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Postoperative Nausea and Vomiting Management Introduction
11.3.4 Novartis AG Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Ani Pharmaceuticals, Inc
11.4.1 Ani Pharmaceuticals, Inc Company Detail
11.4.2 Ani Pharmaceuticals, Inc Business Overview
11.4.3 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Introduction
11.4.4 Ani Pharmaceuticals, Inc Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.4.5 Ani Pharmaceuticals, Inc Recent Development
11.5 Camurus AB
11.5.1 Camurus AB Company Detail
11.5.2 Camurus AB Business Overview
11.5.3 Camurus AB Postoperative Nausea and Vomiting Management Introduction
11.5.4 Camurus AB Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.5.5 Camurus AB Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Detail
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Postoperative Nausea and Vomiting Management Introduction
11.6.4 Sanofi S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.6.5 Sanofi S.A. Recent Development
11.7 Helsinn Holding S.A.
11.7.1 Helsinn Holding S.A. Company Detail
11.7.2 Helsinn Holding S.A. Business Overview
11.7.3 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Introduction
11.7.4 Helsinn Holding S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.7.5 Helsinn Holding S.A. Recent Development
11.8 Eisai Corporation
11.8.1 Eisai Corporation Company Detail
11.8.2 Eisai Corporation Business Overview
11.8.3 Eisai Corporation Postoperative Nausea and Vomiting Management Introduction
11.8.4 Eisai Corporation Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.8.5 Eisai Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Detail
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Postoperative Nausea and Vomiting Management Introduction
11.9.4 Merck and Co. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.9.5 Merck and Co. Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting Management Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
